Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

(DXCM) – Analyzing DexCom’s Short Interest

By Benzinga Insights
Today, 6:43 PM
DexCom’s (NASDAQ:DXCM) short percent of float has risen 18.52% since its last report. The company recently reported that…

DXCM

Read More
1 minute read
  • Movers
  • News

What Does Apple Have To Do With DexCom Stock Trading Lower?

By Ye Kuang
Today, 6:43 PM
DexCom shares (NASDAQ: DXCM) are trading lower on Wednesday following a report that Apple Inc (NASDAQ: AAPL) is making progress on no-prick glucose tracking for its Watch.

AAPL

Read More
6 minute read
  • Entertainment
  • General
  • News
  • Sports

Super Bowl Commercials 2023: The Complete List Of Super Bowl LVII Ads And The Companies Behind Them

By Chris Katje
Today, 6:43 PM
Super Bowl LVII aired Sunday Feb. 12, 2023 and featured dozens of commercials advertising products and showcasing new movies and television shows. The commercials also featured many celebrity cameos and several reunions. Here’s a look at the complete list.

ALPMY

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Equal-Weight on DexCom, Raises Price Target to $110

By Benzinga Newsdesk
Today, 6:43 PM
Barclays analyst Matt Miksic maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and raises the price target from $103 to $110.

DXCM

Read More
1 minute read
  • Analyst Ratings

Analyst Ratings for DexCom

By Benzinga Insights
Today, 6:43 PM
Over the past 3 months, 4 analysts have published their opinion on DexCom (NASDAQ:DXCM) stock. These analysts are…

DXCM

Read More
1 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Lions Gate Entertainment, DexCom, Yelp And Other Big Stocks Moving Higher On Friday

By Lisa Levin
Today, 6:43 PM
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 100 points on Friday. Here are some big stocks recording losses in today’s session.

AYX

Read More
11 minute read
  • Earnings

Earnings Scheduled For February 9, 2023

By Benzinga Insights
Today, 6:43 PM
Companies Reporting Before The Bell • AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.

ABBV

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Wolfe Research Initiates Coverage On DexCom with Outperform Rating, Announces Price Target of $121

By Benzinga Newsdesk
Today, 6:43 PM
Wolfe Research analyst Mike Polark initiates coverage on DexCom (NASDAQ:DXCM) with a Outperform rating and announces Price Target of $121.

DXCM

Read More
1 minute read
  • Analyst Ratings

Analyst Expectations for DexCom’s Future

By Benzinga Insights
Today, 6:43 PM
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

DXCM

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Morgan Stanley Maintains Equal-Weight on DexCom, Raises Price Target to $131

By Benzinga Newsdesk
Today, 6:43 PM
Morgan Stanley analyst Cecilia Furlong maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and raises the price target from $117 to $131.

DXCM

Posts navigation

1 2 … 13 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service